Journal of Lung Pulmonary & Respiratory Research,
Journal Year:
2022,
Volume and Issue:
9(4), P. 107 - 107
Published: Dec. 30, 2022
in
other
areas
and
matched
that
of
the
synthetic
control
group
(Figure
1).
2
COVID-19-symptom-based
testing
has
demonstrated
to
be
not
sensitive
but
specific.
3,4Variation
incidence
asymptomatic
COVID-19
ranged
from
18
81
%
5-7
due
different
laboratory
screening
among
countries'
policies.
The Lancet Global Health,
Journal Year:
2024,
Volume and Issue:
12(7), P. e1184 - e1191
Published: June 13, 2024
Better
access
to
tuberculosis
testing
is
a
key
priority
for
fighting
tuberculosis,
the
leading
cause
of
infectious
disease
deaths
in
people.
Despite
roll-out
molecular
WHO-recommended
rapid
diagnostics
replace
sputum
smear
microscopy
over
past
decade,
large
diagnostic
gap
remains.
Of
estimated
10·6
million
people
who
developed
globally
2022,
more
than
3·1
were
not
diagnosed.
An
exclusive
focus
on
improving
test
accuracy
alone
will
be
sufficient
close
tuberculosis.
Diagnostic
yield,
which
we
define
as
proportion
whom
identifies
among
all
attempt
an
important
metric
adequately
explored.
yield
particularly
relevant
subpopulations
unable
produce
such
young
children,
living
with
HIV,
and
subclinical
As
accessible
non-sputum
specimens
(eg,
urine,
oral
swabs,
saliva,
capillary
blood,
breath)
are
being
explored
point-of-care
testing,
concept
growing
importance.
Using
example
urine
lipoarabinomannan
illustrate
how
even
tests
limited
sensitivity
can
diagnose
if
they
enable
increased
yield.
tongue
swab-based
another
example,
provide
definitions
guidance
design
conduct
pragmatic
studies
that
assess
Lastly,
show
other
characteristics,
cost
implementation
feasibility,
essential
effective
population
coverage,
required
optimal
clinical
care
transmission
impact.
We
calling
incorporated
into
evaluation
processes,
including
WHO
Grading
Recommendations,
Assessment,
Development,
Evaluations
process,
providing
crucial
real-life
complements
traditional
measures.
Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences,
Journal Year:
2023,
Volume and Issue:
381(2257)
Published: Aug. 23, 2023
We
conducted
a
systematic
literature
review
of
general
population
testing,
contact
tracing,
case
isolation
and
quarantine
interventions
to
assess
their
effectiveness
in
reducing
SARS-CoV-2
transmission,
as
implemented
real-world
settings.
designed
broad
search
strategy
aimed
identify
peer-reviewed
studies
any
design
provided
there
was
quantitative
measure
on
transmission
outcome.
Studies
that
assessed
the
effect
testing
or
diagnosis
disease
outcomes
via
treatment,
but
did
not
outcome,
were
included.
focused
among
rather
than
specific
settings;
these
from
anywhere
world
published
time
after
1
January
2020
until
end
2022.
From
26
720
titles
abstracts,
1181
reviewed
full
text,
25
met
our
inclusion
criteria.
These
included
one
randomized
control
trial
(RCT)
remaining
24
analysed
empirical
data
made
some
attempt
for
confounding.
categorized
by
type
intervention:
tracing
(seven
studies);
strategies
(12
isolating
cases/contacts
(four
'test,
trace,
isolate'
(TTI)
part
package
(two
studies).
None
rated
at
low
risk
bias
many
serious
bias,
particularly
due
likely
presence
uncontrolled
confounding
factors,
which
major
challenge
assessing
independent
effects
TTI
observational
studies.
factors
are
be
expected
during
an
on-going
pandemic,
when
emphasis
epidemic
burden
design.
Findings
suggested
important
public
health
role
followed
isolation,
especially
where
mass
serial
used
reduce
transmission.
Some
most
compelling
analyses
came
examining
fine-grained
within-country
tracing;
while
broader
compared
behaviour
between
countries
also
often
found
led
reduced
mortality,
this
universal.
There
limited
evidence
benefit
away
home
environment.
One
study,
RCT,
showed
daily
contacts
could
viable
replace
lengthy
contacts.
Based
scarcity
robust
evidence,
we
able
draw
firm
conclusions
about
impact
different
contexts.
While
majority
scale
is
only
available
scenarios
hence
necessarily
generalizable.
Our
therefore
emphasizes
need
conduct
experimental
help
inform
optimal
Work
needed
support
such
context
future
emerging
epidemics,
along
with
assessments
cost-effectiveness
interventions,
beyond
scope
will
critical
decision-making.
This
article
theme
issue
'The
non-pharmaceutical
COVID-19
pandemic:
evidence'.
BMC Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: July 18, 2023
Spain
had
some
of
Europe's
highest
incidence
and
mortality
rates
for
coronavirus
disease
2019
(COVID-19).
Here
we
describe
the
epidemiology
trends
in
hospitalizations,
number
critical
patients,
deaths
2020
2021.We
performed
a
descriptive,
retrospective,
nationwide
study
using
an
administrative
database,
Minimum
Basic
Data
Set
at
Hospitalization,
which
includes
95-97%
discharge
reports
patients
hospitalized
2021.
We
analyzed
admissions
to
intensive
care
units,
their
geographic
distribution
across
regions
Spain.As
December
31,
2021,
total
498,789
(1.04%
entire
Spanish
population)
needed
hospitalization.
At
least
six
waves
illness
were
identified.
Men
more
prone
hospitalization
than
women.
The
median
age
was
66.
A
54,340
(10.9%
all
hospitalizations)
been
admitted
unit.
identified
71,437
(mortality
rate
14.3%
among
patients).
also
observed
important
differences
regions,
with
Madrid
being
epicenter
hospitalizations
mortality.We
Spain's
response
COVID-19
here
its
experiences
during
pandemic
terms
illness,
deaths.
This
research
highlights
changes
over
several
months
importance
factors
such
as
vaccination,
predominant
variant
virus,
public
health
interventions
rise
fall
outbreaks.
Journal of Clinical Microbiology,
Journal Year:
2024,
Volume and Issue:
62(5)
Published: March 4, 2024
The
landscape
of
at-home
testing
using
over-the-counter
(OTC)
tests
has
been
evolving
over
the
last
decade.
United
States
Food
and
Drug
Administration
Emergency
Use
Authorization
rule
in
effect
since
early
2000s,
it
was
widely
employed
during
severe
acute
respiratory
syndrome
coronavirus
2
pandemic
to
authorize
antigen
nucleic
acid
detection
for
use
central
laboratories
as
well
OTC.
During
pandemic,
first
viruses
became
available
consumer
use,
which
opened
door
additional
virus
OTC
tests.
Concerns
may
exist
regarding
public's
ability
properly
collect
samples,
perform
testing,
interpret
results,
report
results
public
health
authorities.
However,
favorable
comparison
studies
between
centralized
laboratory
test
suggest
that
have
a
place
healthcare,
is
likely
here
stay.
This
mini-review
viral
diseases
will
briefly
cover
regulatory
reimbursement
environment,
current
availability,
advantages
limitations
Journal of Public Health,
Journal Year:
2024,
Volume and Issue:
46(2), P. e279 - e293
Published: Feb. 29, 2024
Abstract
Background
Non-pharmaceutical
interventions
(NPIs)
were
crucial
in
the
response
to
COVID-19
pandemic,
although
uncertainties
about
their
effectiveness
remain.
This
work
aimed
better
understand
evidence
generated
during
pandemic
on
of
NPIs
implemented
UK.
Methods
We
conducted
a
rapid
mapping
review
(search
date:
1
March
2023)
identify
primary
studies
reporting
reduce
transmission.
Included
displayed
an
interactive
gap
map.
Results
After
removal
duplicates,
11
752
records
screened.
Of
these,
151
included,
including
100
modelling
but
only
2
randomized
controlled
trials
and
10
longitudinal
observational
studies.
Most
reported
isolate
those
who
are
or
may
become
infectious,
number
contacts.
There
was
for
hand
respiratory
hygiene,
ventilation
cleaning.
Conclusions
Our
findings
show
that
despite
large
published,
there
is
still
lack
robust
evaluations
need
build
evaluation
into
design
implementation
public
health
policies
from
start
any
future
other
emergency.
The Lancet Microbe,
Journal Year:
2024,
Volume and Issue:
5(5), P. e500 - e507
Published: March 7, 2024
Summary
Antimicrobial
resistance
(AMR)
threatens
human,
animal,
and
environmental
health.
Acknowledging
the
urgency
of
addressing
AMR,
an
opportunity
exists
to
extend
AMR
action-focused
research
beyond
confines
isolated
biomedical
paradigm.
An
learning
system,
AMR-X,
envisions
a
national
network
health
systems
creating
applying
optimal
use
antimicrobials
on
basis
their
data
collected
from
delivery
routine
clinical
care.
AMR-X
integrates
traditional
discovery,
experimental
research,
applied
with
continuous
analysis
pathogens,
antimicrobial
uses,
outcomes
that
are
routinely
disseminated
practitioners,
policy
makers,
patients,
public
drive
changes
in
practice
outcomes.
uses
connected
data-to-action
underpin
evaluation
framework
embedded
care,
continuously
driving
implementation
improvements
patient
population
health,
targeting
investment,
incentivising
innovation.
All
stakeholders
co-create
protecting
by
adapting
evolving
threats
generating
information
needed
for
precision
Diagnostics,
Journal Year:
2025,
Volume and Issue:
15(3), P. 323 - 323
Published: Jan. 30, 2025
Laboratory
testing
has
played
a
pivotal
role
throughout
the
coronavirus
disease
2019
(COVID-19)
pandemic,
exemplifying
importance
of
in
vitro
diagnostics
addressing
public
health
threats
posed
by
outbreaks
infectious
diseases.
This
article
aims
to
present
key
insights
from
our
expertise,
derived
evidence
gathered
during
COVID-19
inform
strategies
for
managing
future
challenges.
Current
scientific
underscores
that
patient
sample
not
only
allows
diagnose
an
acute
severe
respiratory
syndrome
2
(SARS-CoV-2)
infection,
but
also
supports
outbreak
prediction,
improved
control
measures,
anticipation
pressure
on
healthcare
system,
mitigation
adverse
clinical
outcomes,
and
early
detection
emerging
SARS-CoV-2
variants.
Additionally,
wastewater
monitoring
emerged
as
powerful
tool
forecasting
burden,
including
both
prevalence
severity.
Collectively,
these
findings
underscore
value
diagnostic
surveillance
guiding
planning
optimizing
resource
allocation
offering
valid
framework
be
applied
threats,
especially
any
potential
“Disease
X”
may
emerge
future.
PLOS Global Public Health,
Journal Year:
2025,
Volume and Issue:
5(4), P. e0004439 - e0004439
Published: April 24, 2025
Wastewater-based
environmental
surveillance
(ES)
has
been
demonstrated
to
provide
an
early
warning
signal
predict
variant-driven
waves
of
pathogens
such
as
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
Our
study
evaluated
the
potential
cost-effectiveness
ES
for
SARS-CoV-2
compared
with
clinical
testing
alone.
We
used
Covasim
agent-based
model
COVID-19
simulate
disease
transmission
hypothetical
populations
in
Blantyre,
Malawi,
and
Kathmandu,
Nepal.
simulated
introduction
a
new
immune-escaping
variant
over
6
months
estimated
health
outcomes
(cases,
deaths,
disability-adjusted
life
years
[DALYs])
economic
impact
when
using
trigger
moderate
proactive
behavioral
intervention
(e.g.,
increased
use
masks,
social
distancing)
by
policymakers
versus
no
hence
delayed
reactive
intervention.
Costs
considered
included
ES,
testing,
treatment,
productivity
loss
entire
population
due
implementation
calculated
incremental
ratios
these
local
willingness-to-pay
thresholds:
$61
Malawi
$249
performed
sensitivity
analyses
evaluate
key
assumptions
on
results.
are
reported
2022
US
dollars.
estimate
that
if
were
implemented,
approximately
600
DALYs
would
be
averted
Blantyre
300
six-month
period.
Considering
system
costs,
was
cost-effective
cost-saving
Kathmandu.
Cost-effectiveness
highest
settings
low
surveillance,
high
severity,
effectiveness.
However,
from
societal
perspective,
may
not
depending
magnitude
population-wide
losses
associated
threshold.
or
tool
perspective
linked
effective
public
response.
From
however,
length
its
consequences
make
cost-effective.
Implementing
multiple
improve
cost-effectiveness.